LB1593 Real-world experience and clinical utility of a non-invasive gene expression test for primary cutaneous melanoma and validation against high risk driver mutations in BRAF, NRAS and the TERT promoter
2018 ◽
Vol 138
(9)
◽
pp. B21
◽
Keyword(s):
Keyword(s):
Keyword(s):
2019 ◽
Vol 139
(5)
◽
pp. 1127-1134
◽
2020 ◽
Vol 83
(6)
◽
pp. AB147
Keyword(s):
Keyword(s):